www.fdanews.com/articles/196994-novo-nordisk-says-covid-19-helped-boost-sales
Novo Nordisk Says COVID-19 Helped Boost Sales
May 7, 2020
Novo Nordisk said stockpiling related to COVID-19 led to a double-digit percentage increase in the company’s sales in the first quarter of this year.
The Danish drugmaker said sales grew by 14 percent to $4.9 billion in the first three months of the year, with increased prescriptions and wholesaler inventories.
Adjusting for the stockpiling, the company estimated sales growth would have been just 7 percent.